Literature DB >> 27913445

Rate and risk factors for the conversion of fovea-on to fovea-off rhegmatogenous retinal detachment while awaiting surgery.

Andreas Kontos1, Tom H Williamson1.   

Abstract

BACKGROUND/AIMS: Progression of a fovea-on to a fovea-off rhegmatogenous retinal detachment (RRD) while awaiting surgery is rare.
METHODS: A retrospective review of patient records to identify patients in whom a fovea-on retinal detachment at presentation was found to be fovea off at surgery.
RESULTS: We identified 10 cases over 14 years which converted from fovea-on to fovea-off RRD while awaiting surgery. This represented 1.1% of RRDs that were fovea on at presentation (n=930). Nine out of 10 patients had superotemporal RRDs extending to at least the vascular arcade at presentation and all had superotemporal breaks within detached retina, which was significantly higher than the rate for other retinal detachments (100% vs 63%, p=0.02). There were 2.4 breaks per eye, similar to other retinal detachments. Six of the 10 patients converted to a fovea-off retinal detachment within a few hours and the rest by the following day. Visual outcomes were good, with eight patients maintaining their presenting visual acuity and two losing one Snellen line.
CONCLUSIONS: Offering same-day surgery to high-risk fovea-on RRDs may not significantly influence visual outcomes and would only prevent about half of the conversions to fovea off. Superotemporal retinal detachments extending to near the arcades are most at risk and might warrant posturing to limit spread of the detachment in the preoperative period. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Macula; Retina; Treatment Surgery

Mesh:

Year:  2016        PMID: 27913445     DOI: 10.1136/bjophthalmol-2016-309178

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

Review 1.  The urgency of surgical treatment for rhegmatogenous retinal detachment.

Authors:  Nicolas Feltgen; Josep Callizo; Lars-Olof Hattenbach; Hans Hoerauf
Journal:  Ophthalmologe       Date:  2021-03-22       Impact factor: 1.059

2.  Fovea-sparing rhegmatogenous retinal detachments: impact of clinical factors including time to surgery on visual and anatomic outcomes.

Authors:  Irene T Lee; Shaun I R Lampen; Tien P Wong; James C Major; Charles C Wykoff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-11       Impact factor: 3.117

Review 3.  [The urgency of surgical treatment for rhegmatogenous retinal detachment].

Authors:  Nicolas Feltgen; Josep Callizo; Lars-Olof Hattenbach; Hans Hoerauf
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

4.  [Rhegmatogenous retinal detachment : Epidemiology and risk factors].

Authors:  N E Bechrakis; A Dimmer
Journal:  Ophthalmologe       Date:  2018-02       Impact factor: 1.059

5.  Early Structural and Vascular Changes after Within-24 Hours Vitrectomy for Recent Onset Rhegmatogenous Retinal Detachment Treatment: A Pilot Study Comparing Bisected Macula and Not Bisected Macula.

Authors:  Rossella D'Aloisio; Matteo Gironi; Tommaso Verdina; Chiara Vivarelli; Riccardo Leonelli; Cesare Mariotti; Shaniko Kaleci; Lisa Toto; Rodolfo Mastropasqua
Journal:  J Clin Med       Date:  2022-06-17       Impact factor: 4.964

6.  The risk factors of the progression of rhegmatogenous retinal detachment on patients with the fourteen-day quarantine in the early period of COVID-19 outbreak.

Authors:  Meng Zhao; Jipeng Li; Haicheng She; Ningpu Liu
Journal:  BMC Ophthalmol       Date:  2021-05-15       Impact factor: 2.209

7.  Outcomes and eye care knowledge in rhegmatogenous retinal detachment patients with a history of laser refractive surgery for myopia.

Authors:  Chieh Lan; Yi-Hao Chen; Yung-Jen Chen; Jong-Jer Lee; Hsi-Kung Kuo; Pei-Chang Wu
Journal:  Front Public Health       Date:  2022-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.